| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2009 | WO2009081366A1 Palladium and platinum phosphine complexes and their use as anti-tumour agents |
| 07/02/2009 | WO2009081349A1 5-phenyl-lh-benz0 [e] [1, 4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors |
| 07/02/2009 | WO2009081275A2 Antifolate compounds for the treatment of melanoma |
| 07/02/2009 | WO2009081259A1 Phenoxy-pyridyl derivatives |
| 07/02/2009 | WO2009081246A2 Bicyclic diamines as nicotinic receptor agonists |
| 07/02/2009 | WO2009081222A1 Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands |
| 07/02/2009 | WO2009081219A1 Quinazoline derivatives as vanilloid receptor modulators |
| 07/02/2009 | WO2009081217A1 Pharmaceutical formulations containing tolperisone |
| 07/02/2009 | WO2009081208A1 Processes to pregabalin |
| 07/02/2009 | WO2009081197A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 07/02/2009 | WO2009081195A1 Carbamoyl compounds as dgat1 inhibitors 190 |
| 07/02/2009 | WO2009081174A2 Anti - retroviral combination |
| 07/02/2009 | WO2009081117A1 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 07/02/2009 | WO2009081107A1 P-menthawe-3-carboxylic acid esters to treat airways diseases |
| 07/02/2009 | WO2009081105A2 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 07/02/2009 | WO2009081087A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof |
| 07/02/2009 | WO2009081065A2 Method of preparing a material formed from branched molecules comprising associative groups |
| 07/02/2009 | WO2009080853A1 Cis bicyclic complexes of platinum (ii) having anticancer activity |
| 07/02/2009 | WO2009080837A1 Medicament for the treatment of cancer of the pancreas |
| 07/02/2009 | WO2009080836A2 Macrocyclic indoles as hepatitis c virus inhibitors |
| 07/02/2009 | WO2009080835A1 Thyromimetric compounds in treatment of disease related to sonic hedgehog signalling |
| 07/02/2009 | WO2009080828A2 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease |
| 07/02/2009 | WO2009080805A1 Dimeric derivatives of artemisinin and application in anticancer therapy |
| 07/02/2009 | WO2009080795A1 Efficient aspirin prodrugs |
| 07/02/2009 | WO2009080778A2 Preparations with rosehip extracts, and method of producing rosehip extracts |
| 07/02/2009 | WO2009080769A1 Antitumoral compounds |
| 07/02/2009 | WO2009080762A2 Pharmaceutical composition |
| 07/02/2009 | WO2009080761A1 Antitumoral compounds |
| 07/02/2009 | WO2009080744A1 Crystalline form of azelastine |
| 07/02/2009 | WO2009080730A1 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases |
| 07/02/2009 | WO2009080729A1 Oxadiazole derivatives for use as s1p1 agonists in the treatment of autoimmune and inflammatory disorders |
| 07/02/2009 | WO2009080728A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip) |
| 07/02/2009 | WO2009080725A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip) |
| 07/02/2009 | WO2009080724A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 07/02/2009 | WO2009080722A2 Carboxylic derivatives for use in the treatment of cancer |
| 07/02/2009 | WO2009080721A2 4 -aminopyrimidine derivatives as histamine h4 receptor antagonists |
| 07/02/2009 | WO2009080705A2 Bis-thiazole derivatives, process for their preparation and their use as medicaments |
| 07/02/2009 | WO2009080698A1 Active pharmaceutical ingredient on a solid support, amorphous and with an improved solubility |
| 07/02/2009 | WO2009080694A1 Thiazole derivatives used as pi 3 kinase inhibitors |
| 07/02/2009 | WO2009080693A2 Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker |
| 07/02/2009 | WO2009080691A2 Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound |
| 07/02/2009 | WO2009080682A1 Pyrrolo[2,3-d]pyrimidine derivatives as cgrp receptor antagonists |
| 07/02/2009 | WO2009080675A1 Quinoline derivatives with affinity for the 5-ht2b receptor |
| 07/02/2009 | WO2009080663A1 Triazole oxadiazoles derivatives |
| 07/02/2009 | WO2009080651A1 Dosing regimen associated with long acting injectable paliperidone esters |
| 07/02/2009 | WO2009080638A2 Sulfamides as zap-70 inhibitors |
| 07/02/2009 | WO2009080637A1 Compounds which potentiate the ampa receptor and uses thereof in medicine |
| 07/02/2009 | WO2009080546A1 The use of 6-halogeno-[1,2,4]-triazolo-[1,5-a]-pyrimidine compounds for combating pests in and on animals |
| 07/02/2009 | WO2009080534A1 Heterocyclic antiviral compounds |
| 07/02/2009 | WO2009080533A1 Heteroaryl derivatives as orexin receptor antagonists |
| 07/02/2009 | WO2009080523A1 Substituted hydantoins as mek kinase inhibitors |
| 07/02/2009 | WO2009080488A1 Spiroindolinone derivatives as anticancer agents |
| 07/02/2009 | WO2009080482A1 Pharmaceutical compositions comprising octahedral metal (iii) polypyridyl complexes and their use in prevention and treatment of cancer |
| 07/02/2009 | WO2009080470A1 Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders |
| 07/02/2009 | WO2009080432A2 Composition for treatment of tuberculosis |
| 07/02/2009 | WO2009080367A2 Specific inhibitors of pteridine reductase with antiparasitic action |
| 07/02/2009 | WO2009080366A1 A process of making imatinib |
| 07/02/2009 | WO2009080365A1 Pregabalin salts |
| 07/02/2009 | WO2009080364A1 Raloxifene composition |
| 07/02/2009 | WO2009080351A1 Compounds with anti-emetic effect |
| 07/02/2009 | WO2009080314A1 Pyridazine derivatives useful as fungicides and for the treatment of cancer |
| 07/02/2009 | WO2009080301A1 Treatment and prevention of ischaemic cerebral lesions and cerebrovascular cognitive impairment using a treatment regimen consisting of dipyridamole and an angiotensin ii receptor blocker in patients with previous stroke |
| 07/02/2009 | WO2009080291A1 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 07/02/2009 | WO2009080275A1 Extruded rod-shaped devices for controlled release of biological substances to humans and animals |
| 07/02/2009 | WO2009080268A1 Pharmaceutical for the treatment of phantom phenomena |
| 07/02/2009 | WO2009080248A1 Substituted 2-phenylpyrimidine-5-carboxylic acids and the use thereof |
| 07/02/2009 | WO2009080242A1 Substituted 4-aminopyrimidine-5-carboxylic acid and use thereof |
| 07/02/2009 | WO2009080227A2 Pyrazole-carboxamide derivatives as p2y12 antagonists |
| 07/02/2009 | WO2009080226A2 Heterocyclic pyrazole-carboxamides as p2y12 antagonists |
| 07/02/2009 | WO2009080223A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2009 | WO2009080220A1 Polysaccharide derivatives of lipoic acid, their preparation, use as skin cosmetics and medical devices |
| 07/02/2009 | WO2009080200A1 Novel sulphoximide-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| 07/02/2009 | WO2009080199A1 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof |
| 07/02/2009 | WO2009080198A1 Fused cynopryridines and the use thereof |
| 07/02/2009 | WO2009080197A1 Substituted pyrrolo[2, 3-b] and pyrazolo[3, 4-b] pyridines for use as adenosine receptor ligands |
| 07/02/2009 | WO2009080061A1 Sustained-release pharmaceutical formulation containing an antimuscarinic agent and a wetting agent as well as a process for the preparation thereof |
| 07/02/2009 | WO2009080033A1 Compressed chewing gum comprising metformin |
| 07/02/2009 | WO2009080030A1 Treatment of autoimmune hepatitis with a once daily oral dosage form comprising tacrolimus |
| 07/02/2009 | WO2009080025A1 Compressed chewing gum comprising metformin |
| 07/02/2009 | WO2009079941A1 A method for preparing buflomedil |
| 07/02/2009 | WO2009079921A1 Cucurbitane triterpenoid saponins, pharmaceutical composition thereof, preparation and use thereof |
| 07/02/2009 | WO2009079902A1 The preparation and use of a curcumin-zinc compound and its solid dispersion |
| 07/02/2009 | WO2009079878A1 Injection comprising docetaxel and its preparation |
| 07/02/2009 | WO2009079860A1 Medicament for treating obesity or fatty liver disease |
| 07/02/2009 | WO2009079822A1 A bcg polysaccharide nucleic acid extractive and preparation method thereof |
| 07/02/2009 | WO2009079797A1 Compounds and method for treatment of cancer |
| 07/02/2009 | WO2009079790A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | WO2009079775A1 Composition for supporting heat shock protein function comprising glutamine |
| 07/02/2009 | WO2009079768A1 Methods of inhibiting tumor growth using ttk antagonists |
| 07/02/2009 | WO2009079767A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer |
| 07/02/2009 | WO2009079765A1 Compounds with activity at the 5-ht2c receptor |
| 07/02/2009 | WO2009079763A1 Fluorinated aryl amide compounds |
| 07/02/2009 | WO2009079741A1 Compositions and methods affecting heat shock protein expression for improved muscle building |
| 07/02/2009 | WO2009079740A1 Compositions and methods for enhancing hypertrophy in skeletal muscle |
| 07/02/2009 | WO2009079739A1 The use of creatine pyroglutamicacid salt to facilitate increased neural health |
| 07/02/2009 | WO2009079693A1 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 07/02/2009 | WO2009079692A1 Halogenated analogues of anti-fibrotic agents |
| 07/02/2009 | WO2009079683A1 Translocator protein ligands |
| 07/02/2009 | WO2009079679A2 Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists |
| 07/02/2009 | WO2009064819A3 Compositions for the treatment of gastrointestinal inflammation |